NICM
EXAS

Neo Ivy Capital Management’s Exact Sciences EXAS Stock Holding History

Neo Ivy Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,960
Closed -$600K – 401
2025
Q3 		$600K Buy
10,960
+3,404
+45% +$170K 0.15% 212
2025
Q2 		$402K Buy
+7,556
New +$384K 0.13% 209
2022
Q4 		$0 Buy
+6
New +$245 ﹤0.01% 402
2021
Q4 		– Sell
-1,229
Closed -$107K – 491
2021
Q3 		$107K Buy
+1,229
New +$130K 0.12% 236
2021
Q2 		– Sell
-449
Closed -$59K – 499
2021
Q1 		$59K Buy
+449
New +$61.5K 0.06% 310
2020
Q4 		– Sell
-1,226
Closed -$124K – 471
2020
Q3 		$124K Sell
1,226
-3
-0.2% -$259 0.13% 257
2020
Q2 		$107K Buy
+1,229
New +$98.2K 0.12% 236
2020
Q1 		– Sell
-4,003
Closed -$370K – 481
2019
Q4 		$370K Buy
+4,003
New +$352K 0.43% 108
2019
Q3 		– Sell
-9,855
Closed -$1.16M – 318
2019
Q2 		$1.16M Buy
+9,855
New +$993K 0.66% 56

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Neo Ivy Capital Management's EXAS Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 10,960 shares — an estimated $600K sold.

Neo Ivy Capital Management first reported a position in EXAS in Q2 2019 and held it in 9 quarters. The position peaked at $1.16M in Q2 2019. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 10,960 Exact Sciences shares in Q4 2025, an estimated $600K.
  • Neo Ivy Capital Management first reported a position in Exact Sciences in Q2 2019 and held it in 9 quarters.
  • Neo Ivy Capital Management's Exact Sciences position peaked at $1.16M in Q2 2019.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.